http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 05 Mar 2026 16:37:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+ROTHBLATT+MARTINE+A/26119700.html si-local-file:///var/storage/secattach/20260305/26119700.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+ROTHBLATT+MARTINE+A/26119700.html Thu, 05 Mar 2026 16:37:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+ROTHBLATT+MARTINE+A/26119700.html si-local-file:///var/storage/secattach/20260305/26119700.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+ROTHBLATT+MARTINE+A/26119700.html Thu, 05 Mar 2026 16:37:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+05++Filed+by%3A+MAHON+PAUL+A/26119715.html si-local-file:///var/storage/secattach/20260305/26119715.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+05++Filed+by%3A+MAHON+PAUL+A/26119715.html Thu, 05 Mar 2026 16:37:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+05++Filed+by%3A+MAHON+PAUL+A/26119715.html si-local-file:///var/storage/secattach/20260305/26119715.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+05++Filed+by%3A+MAHON+PAUL+A/26119715.html Thu, 05 Mar 2026 16:37:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+Thompson+Tommy+G/26119654.html si-local-file:///var/storage/secattach/20260305/26119654.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+Thompson+Tommy+G/26119654.html Thu, 05 Mar 2026 16:36:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+Thompson+Tommy+G/26119654.html si-local-file:///var/storage/secattach/20260305/26119654.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+Thompson+Tommy+G/26119654.html Thu, 05 Mar 2026 16:36:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+KURZWEIL+RAY/26119672.html si-local-file:///var/storage/secattach/20260305/26119672.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+KURZWEIL+RAY/26119672.html Thu, 05 Mar 2026 16:36:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+KURZWEIL+RAY/26119672.html si-local-file:///var/storage/secattach/20260305/26119672.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+KURZWEIL+RAY/26119672.html Thu, 05 Mar 2026 16:36:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+03++Filed+by%3A+ROTHBLATT+MARTINE+A/26119596.html si-local-file:///var/storage/secattach/20260305/26119596.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+03++Filed+by%3A+ROTHBLATT+MARTINE+A/26119596.html Thu, 05 Mar 2026 16:34:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+03++Filed+by%3A+ROTHBLATT+MARTINE+A/26119596.html si-local-file:///var/storage/secattach/20260305/26119596.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+03++Filed+by%3A+ROTHBLATT+MARTINE+A/26119596.html Thu, 05 Mar 2026 16:34:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+CAUSEY+CHRISTOPHER/26119610.html si-local-file:///var/storage/secattach/20260305/26119610.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+CAUSEY+CHRISTOPHER/26119610.html Thu, 05 Mar 2026 16:34:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+CAUSEY+CHRISTOPHER/26119610.html si-local-file:///var/storage/secattach/20260305/26119610.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++UNITED+THERAPEUTICS+Corp++For%3A+Mar+04++Filed+by%3A+CAUSEY+CHRISTOPHER/26119610.html Thu, 05 Mar 2026 16:34:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+MAHON+PAUL+A/26118700.html si-local-file:///var/storage/secattach/20260305/26118700.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+MAHON+PAUL+A/26118700.html Thu, 05 Mar 2026 16:03:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+MAHON+PAUL+A/26118700.html si-local-file:///var/storage/secattach/20260305/26118700.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+MAHON+PAUL+A/26118700.html Thu, 05 Mar 2026 16:03:00 -0500 O.00186831 UTHR http://www.streetinsider.com/Analyst+PT+Change/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114063.html <p>UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $705.00 (from $655.00) while maintaining a Buy rating.</p><p>The analyst comments: "We reiterate UTHR as our top pick, given an attractive series of catalysts in the near-to- medium term: 1) IPF – stock is likely to see significant upside on clinical trial data in late March / early April + fast approval / accelerated launch could boost momentum. 2) Update on the IP dispute with LQDA (IP expert call) expected any day – we have recently seen delayed legal / IP decisions start to come out http://www.streetinsider.com/Analyst+PT+Change/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114063.html Thu, 05 Mar 2026 04:21:09 -0500 UTHR http://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114063.html <p>UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $705.00 (from $655.00) while maintaining a Buy rating.</p><p>The analyst comments: "We reiterate UTHR as our top pick, given an attractive series of catalysts in the near-to- medium term: 1) IPF – stock is likely to see significant upside on clinical trial data in late March / early April + fast approval / accelerated launch could boost momentum. 2) Update on the IP dispute with LQDA (IP expert call) expected any day – we have recently seen delayed legal / IP decisions start to come out http://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114063.html Thu, 05 Mar 2026 04:21:09 -0500 UTHR http://www.streetinsider.com/Analyst+PT+Change/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114064.html <p>UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $705.00 (from $655.00) while maintaining a Buy rating.</p><p>The analyst comments: "We reiterate UTHR as our top pick, given an attractive series of catalysts in the near-to- medium term: 1) IPF – stock is likely to see significant upside on clinical trial data in late March / early April + fast approval / accelerated launch could boost momentum. 2) Update on the IP dispute with LQDA (IP expert call) expected any day – we have recently seen delayed legal / IP decisions start to come out http://www.streetinsider.com/Analyst+PT+Change/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114064.html Thu, 05 Mar 2026 04:21:09 -0500 UTHR http://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114064.html <p>UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $705.00 (from $655.00) while maintaining a Buy rating.</p><p>The analyst comments: "We reiterate UTHR as our top pick, given an attractive series of catalysts in the near-to- medium term: 1) IPF – stock is likely to see significant upside on clinical trial data in late March / early April + fast approval / accelerated launch could boost momentum. 2) Update on the IP dispute with LQDA (IP expert call) expected any day – we have recently seen delayed legal / IP decisions start to come out http://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114064.html Thu, 05 Mar 2026 04:21:09 -0500 UTHR http://www.streetinsider.com/Analyst+PT+Change/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114065.html <p>UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $705.00 (from $655.00) while maintaining a Buy rating.</p><p>The analyst comments: "We reiterate UTHR as our top pick, given an attractive series of catalysts in the near-to- medium term: 1) IPF – stock is likely to see significant upside on clinical trial data in late March / early April + fast approval / accelerated launch could boost momentum. 2) Update on the IP dispute with LQDA (IP expert call) expected any day – we have recently seen delayed legal / IP decisions start to come out http://www.streetinsider.com/Analyst+PT+Change/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114065.html Thu, 05 Mar 2026 04:21:09 -0500 UTHR http://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114065.html <p>UBS analyst Ashwani Verma raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $705.00 (from $655.00) while maintaining a Buy rating.</p><p>The analyst comments: "We reiterate UTHR as our top pick, given an attractive series of catalysts in the near-to- medium term: 1) IPF – stock is likely to see significant upside on clinical trial data in late March / early April + fast approval / accelerated launch could boost momentum. 2) Update on the IP dispute with LQDA (IP expert call) expected any day – we have recently seen delayed legal / IP decisions start to come out http://www.streetinsider.com/Analyst+Comments/United+Therapeutics+Corp.+%28UTHR%29+PT+Raised+to+%24705+at+UBS/26114065.html Thu, 05 Mar 2026 04:21:09 -0500 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+CAUSEY+CHRISTOPHER/26111617.html si-local-file:///var/storage/secattach/20260304/26111617.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+CAUSEY+CHRISTOPHER/26111617.html Wed, 04 Mar 2026 16:26:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+CAUSEY+CHRISTOPHER/26111617.html si-local-file:///var/storage/secattach/20260304/26111617.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+CAUSEY+CHRISTOPHER/26111617.html Wed, 04 Mar 2026 16:26:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+KURZWEIL+RAY/26111062.html si-local-file:///var/storage/secattach/20260304/26111062.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+KURZWEIL+RAY/26111062.html Wed, 04 Mar 2026 16:08:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+KURZWEIL+RAY/26111062.html si-local-file:///var/storage/secattach/20260304/26111062.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+KURZWEIL+RAY/26111062.html Wed, 04 Mar 2026 16:08:00 -0500 O.00186831 UTHR http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+Thompson+Tommy+G/26111080.html si-local-file:///var/storage/secattach/20260304/26111080.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++UNITED+THERAPEUTICS+Corp+++++++++++++++Filed+by%3A+Thompson+Tommy+G/26111080.html Wed, 04 Mar 2026 16:08:00 -0500 O.00186831 UTHR